Elevation Oncology, Inc. (ELEV)
0.3650
-0.0079 (-2.12%)
Inactive · Last trade price on Jul 22, 2025
Elevation Oncology Employees
Elevation Oncology had 34 employees as of December 31, 2024. The number of employees increased by 5 or 17.24% compared to the previous year.
Employees
34
Change (1Y)
5
Growth (1Y)
17.24%
Revenue / Employee
n/a
Profits / Employee
-$1,411,441
Market Cap
21.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34 | 5 | 17.24% |
| Dec 31, 2023 | 29 | -4 | -12.12% |
| Dec 31, 2022 | 33 | 10 | 43.48% |
| Dec 31, 2021 | 23 | 15 | 187.50% |
| Dec 31, 2020 | 8 | - | - |
ELEV News
- 6 weeks ago - ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV - Business Wire
- 6 weeks ago - Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right - PRNewsWire
- 2 months ago - Elevation Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 3 months ago - Elevation Oncology Presents Preclinical Proof-of-Concept Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025 - PRNewsWire
- 4 months ago - Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025 - PRNewsWire
- 4 months ago - Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70% - Benzinga
- 4 months ago - Elevation Oncology to Discontinue Development of EO-3021; Advancing EO-1022, While Evaluating Strategic Options - PRNewsWire
- 5 months ago - Elevation Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Achievements - PRNewsWire